Edison Investment Research is terminating coverage on Oxford Cannabinoid Technologies (OCTP). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Healthcare |
Update
Healthcare |
edison tv
Healthcare |
Flash note
Healthcare |
Update